| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | 0.23 | 1e-08 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.18 | 8e-07 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.17 | 4e-06 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.17 | 2e-05 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.15 | 4e-05 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0001 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0001 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0001 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | MS-275 | FIMM | pan-cancer | AAC | 0.45 | 0.0004 |